Form 4: Medpace Director Exercises Restricted Stock Units, Increases Common Stock Holdings

Medpace Holdings, Inc. Director Cornelius P. McCarthy III converted 50 restricted stock units into common stock on June 30, 2025, increasing his direct beneficial ownership of common stock.

Summary

• Cornelius P. McCarthy III, a Director of Medpace Holdings, Inc. (MEDP), completed a transaction involving company securities.
• On June 30, 2025, McCarthy converted 50 restricted stock units (RSUs) into 50 shares of Medpace common stock.
• Following this conversion, McCarthy directly beneficially owns 5,387 shares of Medpace common stock.
• He also continues to beneficially own 98 restricted stock units.
• The 198 restricted stock units were originally granted on November 29, 2024, and are scheduled to vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.

Sentiment

Score: 6

Explanation: The filing indicates a routine insider transaction where a director converted restricted stock units into common stock, increasing their direct shareholding. This is generally viewed as a neutral to slightly positive signal, as it demonstrates continued ownership and alignment of interests, but does not reflect new strategic or financial performance.

Positives

• Director Cornelius P. McCarthy III increased his direct beneficial ownership of Medpace common stock by 50 shares, indicating continued alignment with shareholder interests through equity conversion.

Future Outlook

The remaining 98 restricted stock units held by Director McCarthy are scheduled to vest in two approximately equal installments on September 30, 2025, and December 31, 2025.

Industry Context

This Form 4 filing reflects a routine insider transaction, common across all publicly traded companies, where executives and directors convert equity awards into common stock as part of their compensation and ownership structure. It does not provide specific insights into broader industry trends within the clinical research organization (CRO) sector.

Stakeholder Impact

• Shareholders: Increased direct ownership by a director may be seen as a positive signal of confidence and alignment of interests.

Next Steps

• Remaining restricted stock units are scheduled to vest on September 30, 2025, and December 31, 2025.

Key Dates

Recommendation

Keywords

Medpace, MEDP, Form 4, insider transaction, restricted stock units, RSU, director, beneficial ownership, equity compensation